IMODIUM

This brand name is authorized in Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, UK.

Active ingredients

The drug IMODIUM contains one active pharmaceutical ingredient (API):

1	Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE
	By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.
	Read more about Loperamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
IMODIUM Capsule	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02230542, 02291800, 02376016
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00141551, 01689848, 01689854, 01869444, 02334188, 03829609, 04638834, 04910153, 04910176, 04940757, 07296788, 07299261, 07370740, 07374293, 07606533
EE	Ravimiamet	1008997, 1063482, 1603651, 1603662, 1603673
FI	Lääkealan turvallisuus- ja kehittämiskeskus	037669, 080755, 497499, 569277, 569285
FR	Base de données publique des médicaments	60095095, 61203061, 61651634, 65272215, 69522794
GB	Medicines & Healthcare Products Regulatory Agency	18234, 185535, 185536, 19243, 279804, 279805, 289618, 299082, 299083, 81424
HK	Department of Health Drug Office	46489
HR	Agencija za lijekove i medicinske proizvode	HR-H-493726499
IE	Health Products Regulatory Authority	28681, 28706
IL	מִשְׂרַד הַבְּרִיאוּת	3220
LT	Valstybinė vaistų kontrolės tarnyba	1008165, 1015752, 1022765, 1068119, 1069908, 1076666
MT	Medicines Authority	AA565/73301, AA908/06503, MA1471/00301, PI521/01801C, PI908/06501A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	83335
NG	Registered Drug Product Database	04-2941
Switch country to Nigeria in order to find specific presentations of IMODIUM
NL	Z-Index G-Standaard	12310700
NL	Z-Index G-Standaard, PRK	15695, 3212, 85391
NZ	Medicines and Medical Devices Safety Authority	11324, 14818, 15626, 15627
PL	Rejestru Produktów Leczniczych	100105204
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64913001, W64913002, W65625001, W65625002, W65625003, W65625004
SG	Health Sciences Authority	06212P
ZA	Health Products Regulatory Authority	29/11.9/0213, H/11.9/152, J/11.9/166, U/11.9/213